Emcure Pharmaceuticals Ltd PE Ratio

Emcure Pharmaceuticals PE Ratio

Image

Emcure Pharmaceuticals Ltd

NSE: EMCURE

PE

37.1

Last updated on: Sep 19, 2026

Key Highlights

  • The P/E Ratio of Emcure Pharmaceuticals Ltd is 37.1 as of 19 Sep 15:30 PM The P/E Ratio of Emcure Pharmaceuticals Ltd changed from 29.8 on March 2025 to 32.7 on March 2026 . This represents a CAGR of 4.75% over 2 years The Latest Trading Price of Emcure Pharmaceuticals Ltd is ₹ 2015 as of 18 Sep 15:30 The PE Ratio of Pharmaceuticals Industry has changed from 24.6 to 32.4 in 5 years. This represents a CAGR of 5.66% The PE Ratio of Automobile industry is 12.7. The PE Ratio of Finance industry is 16.5. The PE Ratio of IT - Software industry is 18.5. The PE Ratio of Pharmaceuticals industry is 31.7. The PE Ratio of Retail industry is 88.6. The PE Ratio of Textiles industry is 36.7 in 2026 .

Historical P/E Ratio of Emcure Pharmaceuticals Ltd

No data available

Company Fundamentals for Emcure Pharmaceuticals Ltd

Image

Emcure Pharmaceuticals Ltd

NSE: EMCURE

Share Price

₹ 2015.75

105.65 (5.53%)

stock direction

Last updated on: Sep 18, 2026

Market Price of Emcure Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Emcure Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
18 Sep 20262015.75
17 Sep 20261910.1
16 Sep 20261932.25
15 Sep 20261994.15
11 Sep 20261976.75
10 Sep 20261961.8
09 Sep 20261915.2
08 Sep 20261924.15
07 Sep 20261927.15
04 Sep 20261928.55

BlinkX Score for Emcure Pharmaceuticals Ltd

Asset Value vs Market Value of Emcure Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Emcure Pharmaceuticals Ltd38240
Sun Pharmaceutical Industries Ltd440398
Divis Laboratories Ltd248664
Torrent Pharmaceuticals Ltd182738
Zydus Lifesciences Ltd115012
Cipla Ltd110794

PE Ratio of Emcure Pharmaceuticals Ltd Explained

38240

Market cap

1011

Earnings

37.1X

PE Ratio

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Emcure Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Emcure Pharmaceuticals Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Emcure Pharmaceuticals Ltd

No data available

* All values are in %

About Emcure Pharmaceuticals Ltd

  • Emcure Pharmaceuticals Limited was originally incorporated as Emcure Pharmaceuticals Private Limited', as a Private Company, pursuant to a Certificate of Incorporation dated April 16, 1981 issued by Registrar of Companies, Maharashtra at Bombay.
  • Subsequently, Company was converted into a Public Company and the name of Company was changed to Emcure Pharmaceuticals Limited', through a fresh Certificate of Incorporation issued by the RoC, Maharashtra in Pune on September 18, 2001. Emcure Pharmaceuticals an Indian pharmaceutical company engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas.
  • In India, they are present across acute and chronic therapeutic areas, and their key therapeutic areas include gynecology, cardiovascular, vitamins, minerals and nutrients, human immunodeficiency virus antivirals, blood-related and oncology/anti-neoplastics.

Emcure Pharmaceuticals Ltd News Hub

Emcure Pharmaceuticals receives upgrade in credit ratings from CRISIL

Emcure Pharmaceuticals has received upgrade in credit ratings from CRISIL for bank facilities of Rs

Read more

13 Aug 24

Emcure Pharmaceuticals receives upgrade in credit ratings for bank facilities

Emcure Pharmaceuticals announced that CARE Ratings has upgraded the credit ratings assigned to bank

Read more

13 Aug 24

Emcure Pharmaceuticals consolidated net profit rises 10.48% in the June 2024 quarter

Net profit of Emcure Pharmaceuticals rose 10.48% to Rs 144.08 crore in the quarter ended June 2024 a

Read more

14 Aug 24

Emcure Pharmaceuticals to declare Quarterly Result

Emcure Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 August 202

Read more

10 Aug 24

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions